Mistral Pharma Inc. Signs an In-Licensing Deal With Grupo Uriach

Published: Oct 04, 2007

MONTREAL, QUEBEC--(Marketwire - October 04, 2007) - Mistral Pharma Inc. (TSX VENTURE: MIP) ("Mistral") today announced that it has signed a licensing agreement with J. Uriach & CIA, S.A. ("Uriach"), a Grupo Uriach company, for the marketing and distribution of Rupatadine for the Canadian market. Mistral intends to file a new drug submission for TAMALIS™ (Rupatadine) with Health Canada in the first half of 2008.

Back to news